Financhill
Back

Fulcrum Therapeutics Stock Predictions

Fulcrum Therapeutics Stock Forecast

  • Is Fulcrum Therapeutics Stock Undervalued?
    The current Fulcrum Therapeutics [FULC] share price is $3.25. The Score for FULC is 41, which is 18% below its historic median score of 50, and infers higher risk than normal.
  • FULC is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.

Will Fulcrum Therapeutics Stock Go Up Next Year?

Data Unavailable

Fulcrum Therapeutics Stock Rating

Data Unavailable

Fulcrum Therapeutics Stock Price History

Is FULC stock going to rise?

  • Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and FULC is experiencing buying pressure, which is a positive indicator for future bullish movement.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Pharmaceuticals
Sector:
Health Care
Type:
stock
Website:
fulcrumtx.com

52-Week Data

52-Week High:
13.70
52-Week Low:
2.86

Prediction Charts

Market Cap:
175.3M
Price in USD:
3.25
Volume:
812.13K
Beta:
2.30

Technical Analysis

SMA50:
3.40
SMA100:
5.91
SMA200:
7.17
52-Wk Change:
-28.57%

Stock Predictions

  • Is Fulcrum Therapeutics stock public?
    Yes, Fulcrum Therapeutics is a publicly traded company.
  • What is the Fulcrum Therapeutics stock quote today?
    The Fulcrum Therapeutics stock price is 3.25 USD today.
  • How to buy Fulcrum Therapeutics stock online?
    You can buy Fulcrum Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Nov-5 3.28 3.32 3.35 3.21
Nov-6 3.43 3.44 3.48 3.25
Nov-7 3.43 3.49 3.63 3.42
Nov-8 3.50 3.49 3.53 3.38
Nov-11 3.52 3.65 3.72 3.52
Nov-12 3.72 3.65 3.82 3.54
Nov-13 3.94 3.57 3.94 3.52
Nov-14 3.57 3.32 3.57 3.28
Nov-15 3.30 3.01 3.30 2.95
Nov-18 3.01 3.03 3.10 2.93
Nov-19 3.03 3.01 3.03 2.86
Nov-20 2.98 2.99 3.06 2.96
Nov-21 3.02 2.97 3.08 2.96
Nov-22 2.98 3.25 3.30 2.95

Fulcrum Therapeutics Earnings

Data Unavailable

Fulcrum Therapeutics Forecast Revenue Growth

Data Unavailable

  • Analysts estimate an earnings increase this quarter of $0.14 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.50 per share, and a decrease next year of $0.91 per share.

* Fulcrum Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.